tiprankstipranks
Logicbio Therapeutics Inc (LOGC)
NASDAQ:LOGC

Logicbio Therapeutics (LOGC) Financial Statements

0 Followers

Logicbio Therapeutics Financial Overview

Logicbio Therapeutics's market cap is currently ―. The company's EPS TTM is $; its P/E ratio is ―; Logicbio Therapeutics is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.
Jun 22Mar 22Dec 21Sep 21Jun 21
Income Statement-
Total Revenue$ 3.20M$ 2.82M$ 2.03M$ 2.12M$ 802.00K
Gross Profit-----
EBIT$ -4.85M$ -6.44M$ -8.82M$ -9.94M$ -10.22M
EBITDA$ -4.67M$ -6.28M$ -8.64M$ -9.78M$ -10.07M
Net Income Common Stockholders$ -5.04M$ -6.66M$ -9.06M$ -10.19M$ -10.50M
Balance Sheet-
Cash, Cash Equivalents and Short-Term Investments$ 38.85M$ 42.74M$ 53.48M$ 59.58M$ 68.11M
Total Assets$ 47.02M$ 51.90M$ 62.77M$ 68.19M$ 77.88M
Total Debt$ 11.09M$ 12.17M$ 13.25M$ 14.32M$ 15.38M
Net Debt$ -27.76M$ -30.57M$ -40.23M$ -45.26M$ -52.73M
Total Liabilities$ 26.30M$ 26.99M$ 32.04M$ 29.42M$ 33.05M
Stockholders Equity$ 20.72M$ 24.91M$ 30.73M$ 38.76M$ 44.82M
Cash Flow-
Free Cash Flow$ -3.06M$ -9.91M$ -5.27M$ -10.69M$ 4.35M
Operating Cash Flow$ -3.02M$ -9.90M$ -5.16M$ -10.31M$ 4.55M
Investing Cash Flow$ -40.00K$ -7.00K$ -106.00K$ -382.00K$ -201.00K
Financing Cash Flow$ -834.00K$ -833.00K$ -834.00K$ 2.16M$ -180.00K
Currency in USD

Logicbio Therapeutics Earnings and Revenue History

Logicbio Therapeutics Debt to Assets

Logicbio Therapeutics Cash Flow

Logicbio Therapeutics Forecast EPS vs Actual EPS

Currently, no data available
Please return soon. This page is being updated.
What's Included in PREMIUM?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis